AbCellera Biologics Inc. (ABCL)

Last Closing Price: 10.47 (2026-11-19)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

AbCellera Biologics Inc. (ABCL) had Net Income of $-40.76M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$10.64M
Net Income
$-40.76M
--
$10.64M
$63.95M
$-53.31M
$10.50M
$-42.81M
$-42.81M
$-40.76M
$-40.76M
$-40.76M
$-40.76M
$-53.31M
$-44.70M
318.05M
318.05M
$-0.13
$-0.13
Balance Sheet Financials
$876.16M
$410.05M
$623.71M
$1.50B
$70.47M
--
$366.89M
$437.36M
$1.06B
$976.30M
$1.06B
326.33M
Cash Flow Statement Financials
$19.31M
$-197.18M
$214.22M
$155.25M
$190.76M
$35.51M
$35.97M
--
--
Fundamental Metrics & Ratios
12.43
--
--
--
--
100.00%
-501.13%
-501.13%
--
-402.41%
-383.10%
$11.74M
--
--
--
0.01
--
0.59
151.97
-3.84%
-4.17%
-2.72%
-3.84%
$3.26
$0.04
$0.06